H.C. Wainwright Upgrades Arcturus Therapeutics (ARCT) to Buy, 'Expecting ARCT-154 Approval in Japan As COVID-19 Vaccine and Booster in 2023'
Tweet Send to a Friend
(Updated - May 11, 2023 6:21 AM EDT)
H.C. Wainwright analyst Ed Arce upgraded Arcturus Therapeutics (NASDAQ: ARCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Ed Arce upgraded Arcturus Therapeutics (NASDAQ: ARCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
